Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InUtero Therapeutics is a clinical-stage biotechnology company focused on developing life-saving therapies for fetuses with devastating genetic conditions. Founded by Dr. Tippi MacKenzie, a pioneer in fetal surgery and Director of the UCSF Center for Maternal-Fetal Precision Medicine, the company leverages in utero delivery to treat diseases before birth. Their approach aims to prevent irreversible organ damage and induce immune tolerance to postnatal treatments. The company's lead programs include in utero enzyme replacement therapy (IUERT) for lysosomal storage disorders and hematopoietic stem cell transplantation for alpha thalassemia major. InUtero Therapeutics represents a paradigm shift in pediatric medicine by treating patients at the earliest possible stage of development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tippi Mackenzie.